Frailty and risk in proximal aortic surgery  by Ganapathi, Asvin M. et al.
A
C
D
Acquired Cardiovascular Disease Ganapathi et alFrailty and risk in proximal aortic surgeryAsvin M. Ganapathi, MD,a Brian R. Englum, MD,a Jennifer M. Hanna, MD,a Matthew A. Schechter, MD,a
Jeffrey G. Gaca, MD,a Lynne M. Hurwitz, MD,b and G. Chad Hughes, MDaFrom th
and D
Disclosu
and M
comm
Read at
Coeu
Receive
for pu
Address
Divis
Cente
0022-52
Copyrig
http://dx
186Objectives: Although frailty has recently been examined in various populations as a predictor of morbidity and
mortality, its effect on thoracic aortic surgery outcomes has not been studied. The objective of the present study
was to evaluate the role of frailty in predicting postoperative morbidity and mortality in patients undergoing
proximal aortic replacement surgery.
Methods: A retrospective analysis of a prospectively maintained database was performed for all patients
undergoing elective and nonelective proximal aortic operations (root, ascending aorta, and/or arch) at a single-
referral institution from June 2005 to December 2012. A total of 581 patients underwent proximal aortic surgery,
of whom 574 (98.8%) were included in the present analysis; 7 were excluded because of incomplete data. Frailty
was evaluated using an index consisting of age>70 years, body mass index<18.5 kg/m2, anemia, history of
stroke, hypoalbuminemia, and total psoas volume in the bottom quartile of the population. One point was given
for each criterion met to determine a frailty score of 0 to 6. Frailty was defined as a score of2. Risk models for
length of stay>14 days, discharge to other than home, 30-day composite major morbidity, 30-day composite ma-
jormorbidity/mortality, and 30-day and 1-yearmortality were calculated usingmultivariate regressionmodeling.
Results: Of the 574 patients, 148 (25.7%) were defined as frail (frailty score 2). The unadjusted
30-day/in-hospital and long-term outcomes were significantly worse for the frail versus nonfrail patients
in all but 1 of the outcomes analyzed; no difference was found in the 30-day readmission rates between
the 2 groups. In the multivariate model, a frailty score of 2 was associated with discharge to other than
home and 30-day and 1-year mortality.
Conclusions: Frailty, as defined using a 6-component frailty index, can serve as an independent predictor of
discharge disposition and early and late mortality risk in patients undergoing proximal aortic surgery. These frailty
markers, all of which are easily assessed preoperatively, could provide valuable information for patient counseling
and risk stratification before proximal aortic replacement. (J Thorac Cardiovasc Surg 2014;147:186-91)Supplemental material is available online.
Repairs of the ascending thoracic aorta and arch have been
demonstrated to carry significant potential morbidity and
mortality risk.1,2 A recent study from The Society of
Thoracic Surgeons (STS) Adult Cardiac Surgery Database
examining outcomes in 45,894 patients undergoing
ascending aorta replacement (with or without root), with
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The Journal of Thoracic and Cardiovascular Surgnonelective case status to be the strongest predictor of
major morbidity or mortality, although other comorbid
conditions such as severe chronic lung disease, chronic
kidney disease, and cerebrovascular disease also predicted
an increased risk.2 Frailty, defined as a state of increased
vulnerability to stressors caused by deterioration across
multiple physiologic systems, is an independent risk factor
for in-hospital mortality, reduced midterm survival, and
prolonged residential care requirements in cardiac surgery.3
Frailty was not examined in the aforementioned large STS
Adult Cardiac Surgery Database study, and no other work to
date has attempted to examine the effect of frailty on
thoracic aortic surgery outcomes. Therefore, the present
study sought to establish an objective frailty score for
patients undergoing proximal aortic surgery and to evaluate
its independent predictive value relative to known risk
factors to further improve on existing risk stratification
models.METHODS
Patients and Data Source
A retrospective analysis of a prospectively maintained database was
performed for all patients undergoing elective and nonelective proximal
aortic operations at a single tertiary referral institution from June 2005ery c January 2014
Abbreviations and Acronyms
FP ¼ frail patient
NFP ¼ nonfrail patient
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Dto December 2012. Proximal aortic surgery was defined as any procedure
involving the aortic root, ascending aorta, and/or aortic arch, performed
through a median sternotomy, and using cardiopulmonary bypass with
or without hypothermic circulatory arrest. Operations classified as hybrid
arch procedures or involving the descending thoracic aorta were
excluded. The pre-, intra-, and postoperative variables were obtained
from the Duke Thoracic Aortic Surgery Database, a prospectively
maintained clinical registry of all patients undergoing thoracic aortic
surgery at Duke University Medical Center (Durham, NC). The need
for individual patient consent was waived after review and approval by
the institutional review board of Duke University. A query of the database
identified 581 proximal aortic procedures performed from June 2005 to
December 2012. Of these, 574 (98.8%) were included in the present
analysis; 7 patients were excluded because of incomplete data. The
comorbidities and patient characteristics were defined using STS
definitions.4 All patients underwent annual follow-up examinations at
the Duke University Center for Aortic Disease with clinical assessment
and computed tomographic angiography, magnetic resonance angio-
graphy, and/or echocardiography. Data were collected through the last
follow-up visit by the study termination date of December 2012. In
addition, the Social Security Death Index (available at: http://ssdi.
rootsweb.com/) was queried to confirm all deaths and survey for patients
lost to follow-up.
Frailty Definition
To classify frailty, a score consisting of 6 components previously
identified in the published data as objective indicators of frailty was
created. The components were (1) age >70 years,5 (2) body mass
index<18.5 kg/m2,6 (3) anemia (<12.0 g/dL for women,<13.0 g/dL for
men),7 (4) hypoalbuminemia (<3.5 g/dL),8 (5) a history of stroke,9 and
(6) a total psoas volume (TPV) in the bottom quartile of the patient
population.10 For each characteristic a patient fulfilled, they received
1 point to establish a score from 0 to 6. Any patient with a score of
2 was defined as frail, analogous to previously published definitions.5,9
Any missing value among the components of the frailty score was
considered normal.
TPV measurements were made using a TeraRecon Aquarius
3-dimensional workstation (TeraRecon Inc, San Mateo, Calif) for all
patients with computed tomography scans of the abdomen and pelvis
extending to the acetabulum (n ¼ 265; 46.1%). To perform the TPV
measurements, the region of interest tool was used to outline the psoas
muscle bilaterally on axial images (Figure E1). The selection of the psoas
muscle began at the L1 level and continued through the acetabulum,
with measurements made at each vertebral level and at approximately
3 equidistant measurements between the top of the sacrum and the
acetabulum (total of 8 measurements). Once the psoas muscle had been
outlined at the 8 predetermined locations, the volume tool was used to
determine the TPV. To account for the potential inclusion of fat or other
tissue within the psoas volume, density thresholds of 0 to 161 Hounsfield
units, consistent with previous data,10 were used to select muscle and
exclude fat, vasculature, and bone. The resultant TPV was then
calculated. Three independent observers, who were unaware of the
patient’s clinical information, performed the TPV measurements, with
multiple measurements made for randomly assigned scans (one third of
all measurements) to validate interobserver reliability.The Journal of Thoracic and CaOutcomes
The primary outcome measure was mortality, both 30 day and 1 year.
The secondary outcomes included length of stay>14 days, discharge to
a destination other than home, readmission within 30 days, composite
30-day major morbidity, and composite 30-day major morbidity and
mortality. The composite 30-day major morbidity was defined using the
standard STS definition and included reoperation, prolonged mechanical
ventilation, acute renal failure, new onset dialysis, and stroke.
Statistical Analysis
Categorical variables were compared using the chi-square test
and continuous variables using Student’s t test. Backward, stepwise,
multivariate logistic regression modeling was used to determine the
independent effect of frailty on these outcomes, while controlling for
known risk factors. A Kaplan-Meier survival analysis with the log-rank
test was used for the long-term survival estimates. The significance levels
were set at an a of 0.05 in all cases. We made an affirmative decision to
control for a type I error at the level of the comparison; therefore, no
corrections for multiple hypothesis testing were made. Statistical analysis
was performed using R, version 2.15.1 (Vienna, Austria).RESULTS
The study cohort consisted of 574 total procedures in
569 patients. Of these patients, 148 (25.7%) were defined
as frail (frailty score 2). The frail patients (FPs) were
older and more likely to be women. They also had a
greater comorbid disease burden, including a more frequent
history of previous stroke and/or transient ischemic attack,
chronic obstructive pulmonary disease, and chronic renal
insufficiency, and were more likely to be American Society
of Anesthesiologists class 4 (Table 1). The patients in the
frail and nonfrail groups did not differ in the type of
proximal aortic procedure performed or the incidence of
redo sternotomy (Table 2). However, the FPs were more
likely to undergo nonelective (urgent and emergent)
surgery, including more frequent surgery for aortic
dissection, and were also significantly more likely to require
concomitant cardiac surgical procedures, most of which
were coronary artery bypass grafting (76%).
Examination of the individual frailty characteristics
revealed that 280 of the 426 (65.7%) nonfrail patients
(NFPs) did not meet any of the frailty criteria. Of the
NFPs fulfilling only 1 frailty criterion, the most common
finding was the presence of anemia (n ¼ 60; 14.1%). In
contrast, anemia (n ¼ 112; 75.7%) and hypoalbuminemia
(n ¼ 104; 70.3%) were the most common characteristics
present in the FPs (Table E1). Nearly all FPs had a frailty
score of 2 or 3 (n ¼ 140; 94.6%), with no patient having
a score of 6 (Table E2). Fewer than one half of the FPs
(n ¼ 66; 44.6%) were elderly, defined as age>70 years.
The unadjusted perioperative (30-day and in-hospital) and
long-term outcomes revealed significant differences
between the FPs and NFPs in all but 1 of the outcomes
analyzed (Table 3). The single exception was the absence
of a difference in the 30-day readmission rates between
the 2 groups. Mortality at 30 days and 1 year for the entirerdiovascular Surgery c Volume 147, Number 1 187
TABLE 1. Preoperative patient characteristics
Variable
Overall
(n ¼ 574)
Frail
(n ¼ 148)
Not frail
(n¼426)
P
value
Demographics
Age (y) 56.1  14.4 63.4  14.7 53.5  13.4<.01*
Male gender 404 (70.3) 80 (54.1) 324 (76.1) <.01*
White race 430 (74.9) 86 (58.1) 344 (80.7) <.01*
BMI (kg/m2) 28.5  6.2 27.8  6.9 28.7  5.9 .13
Comorbidities
Hypertension 448 (78.0) 127 (85.8) 321 (75.4) <.01*
Hyperlipidemia 288 (50.1) 85 (57.4) 203 (47.7) <.01*
History of tobacco use 265 (46.2) 76 (51.4) 189 (44.4) .14
Diabetes 49 (8.5) 17 (11.5) 32 (7.5) .14
Coronary artery disease 131 (22.8) 55 (37.2) 76 (17.8) <.01*
History of stroke or TIA 40 (7.0) 25 (16.9) 15 (3.5) <.01*
COPD 72 (12.5) 36 (24.3) 36 (8.5) <.01*
Baseline creatinine
>1.5 mg/dL
64 (11.2) 32 (21.6) 32 (7.5) <.01*
Peripheral vascular
disease
30 (5.2) 12 (8.1) 18 (4.2) .07
Baseline laboratory values
Hemoglobin (g/dL) 13.2  2.0 11.2  1.8 13.9  1.5 <.01*
Albumin (g/dL)y 3.7  0.5 3.2  0.5 3.9  0.3 <.01*
Operative information
Ejection fraction 52.6  6.2 52.3  6.8 52.7  6.1 .58
ASA class 4 182 (31.7) 72 (48.6) 110 (25.8) <.01*
Maximal aortic diameter 5.6  1.1 5.7  1.5 5.6  1.0 .35
Data presented as mean  standard deviation or n (%). BMI, Body mass index;
TIA, transient ischemic attack; COPD, chronic obstructive pulmonary disease;
ASA,American Society of Anesthesiologists. *Statistically significant. yOnly patients
with preoperative albumin level available were included.
TABLE 3. Unadjusted perioperative and long-term outcomes
Outcome
Overall
(n ¼ 574)
Frail
(n ¼ 148)
Not frail
(n ¼ 426)
P
Value
Length of stay>14 d 47 (8.2) 23 (15.5) 24 (5.6) <.01*
Discharge to location
other than home
39 (6.7) 25 (16.9) 14 (3.2) <.01*
Readmission within
30 d
54 (9.4) 15 (10.1) 39 (9.2) .72
Composite 30-d
major morbidity
111 (19.3) 42 (28.4) 69 (16.2)<.01*
Composite 30-d major
morbidity and
mortality
120 (20.9) 47 (31.8) 73 (17.1)<.01*
30-d Mortality 19 (3.3) 13 (8.8) 6 (1.4) <.01*
1-y Mortalityy 38/482 (7.8) 23/127 (18.1) 15/355 (4.2) <.01*
Data presented as n (%). *Statistically significant. yOnly patients with at least 1 year
of follow up included in the analysis (n ¼ 482).
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but only 1.4% and 4.2% for the nonfrail group. Mortality
was significantly increased in the frail cohort at 8.8% and
18.1% at 30 days and 1 year, respectively.
Using multivariate logistic regression modeling,
frailty was independently associated with discharge to aTABLE 2. Operative characteristics
Variable
Overall
(n ¼ 574)
Frail
(n ¼ 148)
Not frail
(n ¼ 426)
P
value
Indication
Dissection 145 (25.3) 64 (43.2) 81 (19.0) <.01*
Procedure performed
RR/ASC only 113 (19.7) 26 (17.6) 87 (20.4) .45
RR/ASC with hemiarch 419 (73.0) 107 (72.3) 312 (73.2) .82
RR/ASC with total arch 42 (73.2) 15 (10.1) 27 (6.3) .13
Redo sternotomy 139 (24.2) 38 (25.7) 101 (23.7) .63
Concomitant cardiac
surgical procedure
137 (23.7) 50 (33.8) 87 (20.4) <.01*
Case status
Elective 425 (74.0) 83 (56.1) 342 (80.3) <.01*
Urgent 71 (12.4) 34 (23.0) 37 (8.7) <.01*
Emergent 78 (13.6) 31 (20.9) 47 (11.0) <.01*
Data presented as n (%). RR/ASC,Root replacement or ascending aorta. *Statistically
significant.
188 The Journal of Thoracic and Cardiovascular Surgdestination other than home and 30-day and 1-year
mortality, with risk-adjusted odds ratios of 3.7 (95%
confidence interval, 1.8-7.7; P<.01), 5.0 (95% confidence
interval, 2.4-9.7; P<.01), and 4.5 (95% confidence interval
2.1-9.6; P < .01), respectively (Table 4). Total arch
replacement was significantly associated with all outcomes
examined, except for the 30-day readmission rate. None of
the variables, including frailty, were retained after
attempting to create a backward, stepwise, multivariate
logistic regression model for 30-day readmission
(all variables removed from model using P > .2, as
determined a priori). Consequently, no statistically
significant model for 30-day readmission was created.
Late survival, assessed using Kaplan-Meier analysis with
the log-rank test, revealed significantly worse long-term
survival among the frail cohort (Figure 1).
DISCUSSION
Although risk models have recently been developed for
30-day and in-hospital major morbidity and mortality in
proximal thoracic aortic surgery,2 no study has examined
the effect of frailty in this population, for either short- or
long-term outcomes. The present study has presented a novel
frailty scoring system that uses easily assessed, objective
preoperative variables that can quickly assess an individual
patient’s frailty status. Defined by a score of 2, frailty was
independently associatedwithdischarge to a destinationother
than home and 30-day and 1-year mortality. Consistent with
the existing data, the FPs were older and had a greater
comorbid disease burden.5,11-13 Fewer than one half were
elderly, suggesting age alone is an insufficient marker of
this state of physiologic deterioration. The present study
was also unique in presenting risk models for 1-year
mortality, information that could be useful to clinicians
when counseling patients and their families.
Given the increasing age of patients undergoing cardiac
surgery14,15 and the significant potential for morbidity andery c January 2014
TABLE 4. Multivariate predictors of outcome in proximal aortic replacement
Variable LOS>14 d
Discharge to
destination other
than home
Composite 30-d
morbidity
Composite 30-d
morbidity and
mortality 30-d mortality 1-y mortality
Frail status NS 3.7 (1.8-7.7;<.01) NS NS 5.0 (1.8-14.0;<.01) 4.5 (2.1-9.6;<.01)
ASA class 4 NS 2.7 (1.3-5.7;<.01) NS NS NS NS
CCP 5.0 (2.5-9.9;<.01) NS 3.7 (2.3-5.9;<.01) 3.5 (2.2-5.6;<.01) NS NS
Female gender 2.2 (1.1-4.5; .03) NS NS NS NS NS
Nonelective status 4.2 (2.1-8.8;<.01) NS 3.6 (2.3-5.7;<.01) 3.6 (2.3-5.7;<.01) NS NS
PVD NS 3.5 (1.2-10.4; .02) NS NS NS NS
Presence of aortic
dissection
NS NS NS NS 3.1 (1.2-8.5; .03) 2.3 (1.1-4.7; .03)
Renal insufficiency 3.3 (1.5-7.1;<.01) 3.8 (1.8-8.3;<.01) NS NS NS NS
Total arch replacement 10.8 (4.4-26.6;<.01) 3.0 (1.2-8.0; .02) 3.7 (1.8-7.7;<.01) 4.8 (2.4-9.7;<.01) 4.9 (1.7-14.6;<.01) 7.7 (3.3-18.1;<.01)
Data presented as odds ratio (95% confidence interval; P value). LOS, Length of stay; NS, nonsignificant; ASA,American Society of Anesthesiologists;CCP, concomitant cardiac
surgical procedure; PVD, peripheral vascular disease.
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Dmortality in proximal thoracic aortic surgery, especially in
the nonelective setting,2 a better understanding of all
potential risk factors for these procedures is necessary.
The current risk models, such as the STS Risk Calculator,
EuroSCORE, and Ambler score, attempt to provide
estimates of postoperative mortality risk; however,
concerns exist regarding their utility for high-risk patients
and the lack of data on long-term mortality.16-21 The STS
Risk Calculator and Ambler score do not provide risk
stratification for isolated proximal aortic surgery, and it
has been suggested that they do not appropriately assess
elderly patients, because they do not account for
physiologic reserve.3 Thus, frailty is believed to provide
the missing element to appropriately determine the
operative risks in this population.
Originally used to describe elderly medical patients in the
community,12,22,23 the concept of frailty has recently beenFIGURE 1. Unadjusted Kaplan-Meier survival curves for frail and
nonfrail patients.
The Journal of Thoracic and Castudied in various surgical populations.9,11,24 However,
many of the current methods used to determine frailty
rely on subjective assessments or require significant effort
to conduct all the necessary evaluations.25-28 Lee and
colleagues5 reported the first study of frailty in cardiac
surgery patients. They examined its effect on elective
cardiac surgery outcomes.5 Defined as the presence of
impairment of activities of daily living, ambulation, or
dementia, they reported worse outcomes for patients
classified as frail.5 S€underman and colleagues13 presented
a more comprehensive measure of frailty in elderly
patients, including objective data, such as laboratory values,
pulmonary function tests, and grip strength, and subjective
assessments of self-reported exhaustion and physical
activity scores. Similarly, a poor prognosis of the FPs
relative to the NFPs was noted in their study. However, their
assessment was dependent on extensive observation of the
patients, which might not be feasible at all institutions or
in nonelective clinical settings. They also relied on
subjective data that could vary among patients.13 Recently,
the advent of transcatheter aortic valve replacement, which
has been proposed as an alternative treatment option for
aortic stenosis in high-risk and inoperable patients, has
spurred others to assess the role of frailty in valve
replacement.3,29,30 One metric frequently used in
transcatheter aortic valve replacement assessment has
been the 6-minute walk test, which has been found to
provide additive prognostic value to the EuroSCORE,
although the utility of this test has also been limited because
it is not generally obtainable in the nonelective setting.31
Unlike previous work, the definition of frailty presented
in the present study allows for the efficient identification
of FPs using only easily obtained, objective preoperative
data. All 6 of the characteristics used to calculate the frailty
score have been previously described as markers of frailty
in the published data.6,7,9,32 Anemia, hypoalbuminemia,
and a low body mass index can have negative effects on
the physiologic reserve and were important for inclusion.rdiovascular Surgery c Volume 147, Number 1 189
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definition, because this can lead to impaired ability to
perform activities of daily living, ambulate, or function
independently. The use of TPV in the lowest quartile of
the measurements as the last criteria in the scoring system
stemmed from recent data describing a total psoas area at
a specified vertebral level as a surrogate for frailty that
has been associated with reduced survival in surgical
patients.10,32,33 Because no definitive numerical values
exist for which total psoas area would indicate a FP, we
believed it appropriate to use the TPV instead.
Measurement of the TPV accounts for the entire muscle,
eliminating the potential sampling error of quantifying the
area at 1 vertebral level. Additionally, TPV measurements
can be made easily using the methods we have described.
Previous studies defined the lowest quartile of TPV in the
studied population to be an appropriate frailty marker, and
we used the same convention.10 To address the potential
of nonreproducibility of measurements, an interobserver
intraclass correlation coefficient of 0.98 was calculated
among the measurements from 3 independent observers,
strongly suggesting the reliability of the independent
measurements. Finally, measurement of the TPV takes
approximately 5 minutes to complete, reinforcing its
ease of use. However, should one not have access to a
3-dimensional workstation, required to calculate the TPV,
repeat analysis of the data, removing the TPV from the
frailty score, led to 17 patients originally classified as frail
to be reclassified as nonfrail. Although the overall results
of the multivariate model did not change, with frailty
remaining an independent risk factor for discharge to a
destination other than home and 30-day and 1-year
mortality, a small, but noticeable, decrease occurred in
the strength of the statistical significance of the frailty
variable (data not shown). Therefore, these results suggest
that, if unavailable, frailty can be classified without the
TPV, although a more accurate prediction of outcomes
will be seen with inclusion of TPV in the frailty
determination.
One important aspect of the novel frailty definition
proposed in the present study is its applicability to
all age groups. Historically, frailty has been used
to describe only elderly patients, usually those aged
>65 years. However, the disease processes that contribute
to proximal thoracic aortic pathology often affect
younger patients and may also contribute to a diminished
physiologic reserve. Therefore, the inclusion of multiple
factors to assess frailty in younger patients was thought
to be important. Consistent with this supposition,
fewer than one half of the FPs in the present study were
aged>70 years.
Another important point to consider is the association of
frailty with 1-year mortality. Previous risk models and
definitions of frailty have focused on the short-term190 The Journal of Thoracic and Cardiovascular Surgoutcomes and thus have failed to capture any deaths
occurring beyond the 30-day and/or in-hospital peri-
operative window. The lack of data in that period is less
than ideal, because patients not fulfilling traditional risk
factors, but with diminished physiologic reserve, could be
particularly susceptible to major morbidity and/or mortality
beyond 30 days. Additionally, it has been suggested that
some assessment of frailty might be important when
considering the benefit of a procedure for a given patient,
particularly in the elderly.28 Thus, classifying patients as
frail has the potential to offer surgeons another tool to
risk stratify operative candidates and provide appropriate
preoperative counseling, because patients experiencing
1-year mortality generally do not obtain a meaningful
survival benefit from their procedure.34
Also warranting discussion is the incidence of frailty and
the distribution of frailty scores within the study cohort.
Nearly one half the patients (48.7%) did not meet any of
the specified criteria, and 74.2% of patients were considered
not frail. Estimates of frailty in community middle-age
(aged 50-64 years) and elderly patients (aged 65 years)
have ranged from1% to 8% and 6% to 27%, respectively.35
The incidence of frailty in cardiac surgery patients has
ranged from 4% to 50%.5,13 The proportion of FPs
(25.7%) in the present study was within these ranges. It
should be noted that differences in the number of FPs
between studies were likely secondary to alternative
definitions and disparate patient populations. In the
present study, almost all FPs fulfilled only 2 or 3 criteria,
with just 8 FPs (5.4%) having a frailty score of 4, and
none having a score of 6. This distribution of frailty scores
might represent patient selection at our institution.
Although it would have been desirable to examine the
effect of an increasing frailty score on morbidity and
mortality, the distribution of these scores, and the low
event rate in the study, precluded any meaningful
statistical analysis of a progressively elevated frailty score.
Finally, no difference was found in the 30-day readmission
rate between the FP and NFPs. This observation can be ex-
plained by the increased likelihood of FPs being discharged
to skilled nursing facilities and having a longer length of stay
and, thus, minimizing their 30-day readmission rate.
Study Limitations
The present study had a number of important limitations.
First, the study was a single-institution, retrospective study
and, consequently, was subject to various forms of bias.
Additionally, we had 394 missing values (11.1%; 85
missing albumin values and 309 missing psoas values),
which were assumed to be normal. This assumption
could have underestimated the number of FPs and,
ultimately, affected the presented results. Finally, given
the single-institution nature of the study, the outcomes
presented might not be generalizable to other centers.ery c January 2014
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The concept of frailty is becoming an increasingly
important topic to consider in the current era of cardiac
surgery, because, given the aging of the population, the
number of elderly and infirm patients referred for possible
surgical management of their aortic disease has continued
to increase. A better understanding of this previously
subjective term will help guide patient selection and allow
surgeons to provide objective risk stratification using the
easily calculated frailty definition we have presented. We
have demonstrated that classification of frailty, as defined
by the presence of any 2 of 6 preoperative characteristics,
including age>70 years, low body mass index, anemia,
hypoalbuminemia, a history of stroke, and low TPV, is
independently associated with discharge to a destination
other than home and poorer 30-day and/or in-hospital and
1-year survival after proximal aortic replacement surgery.
Furthermore, this frailty risk is independent of that
predicted using traditional risk factors.
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FIGURE E1. Representation of total psoas volume (TPV) measurement. A, Axial image of abdomen at L4 level, with red line outlining psoas muscles
bilaterally. B, Three-dimensional image of bilateral psoas muscles, including calculation of TPV, after reconstruction on 3-dimensional workstation.
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DTABLE E1. Frailty indicators
Component Frail (n ¼ 148) Not frail (n ¼ 426)
Age>70 y 66 (44.6) 26 (6.1)
BMI<18.5 kg/m2 7 (4.7) 5 (1.1)
History of stroke 25 (16.9) 15 (3.5)
TPV in lower quartile 46 (31.1) 20 (4.7)
Anemia 112 (75.7) 60 (14.1)
Hypoalbuminemia 104 (70.3) 20 (4.7)
Data presented as n (%). Anemia defined as<12.0 g/dL for women or<13.0 g/dL for
men. Hypoalbuminemia defined as<3.5 g/dL. BMI, Body mass index; TPV, total
psoas volume.
TABLE E2. Frailty scores
Frailty score Frail (n ¼ 148) Not frail (n ¼ 426)
0 NA 280 (65.7)
1 NA 146 (34.3)
2 93 (62.8) NA
3 47 (31.8) NA
4 7 (4.7) NA
5 1 (0.7) NA
6 0 (0) NA
Data presented as n (%). NA, Not applicable.
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